John Shannon is Chief Executive Officer of Xeris Biopharma Holdings, Inc. (XERS). The company reported total compensation of $5,042,584 for fiscal year 2025.
| Salary | $742,334 |
|---|---|
| Bonus | $0 |
| Stock awards | $2,848,000 |
| Option awards | $838,615 |
| Non-equity incentive plan | $607,971 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $5,664 |
| Total | $5,042,584 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Xeris Biopharma Holdings, Inc. filed April 23, 2026, accession 0001867096-26-000021.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $742,334 | $0 | $2,848,000 | $838,615 | $607,971 | $0 | $5,664 | $5,042,584 |
| FY2024 | Chief Executive Officer | $629,193 | $0 | $2,452,500 | $309,037 | $433,475 | $0 | $2,904 | $3,827,109 |
| FY2023 | Chief Executive Officer | $571,411 | $0 | $930,000 | $0 | $343,949 | $0 | $2,793 | $1,848,153 |
Totals as disclosed in each year's own compensation disclosure for Xeris Biopharma Holdings, Inc..
| Peer-group chief executive median | $4,557,590 |
|---|---|
| Difference from that median | $484,994 |
| Percentile within the disclosed peer group | 55th |
| Peers with a disclosed figure | 11 |
Medians and percentiles are computed across the peer group Xeris Biopharma Holdings, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| John Shannon this page | Chief Executive Officer | $5,042,584 |
| Kevin McCulloch | President and Chief Operating Officer | $2,270,973 |
| Anh Nguyen | Chief Medical Officer | $2,000,648 |
| Beth Hecht | Chief Legal Officer and Corporate Secretary | $1,895,274 |
| Steven Pieper | Chief Financial Officer | $1,874,090 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Xeris Biopharma Holdings, Inc. compensation brief.
John Shannon's compensation sits inside Xeris Biopharma Holdings, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Xeris Biopharma Holdings, Inc. (XERS) compensation brief